Line Plot from Scientific Research

Proliferation of the PDCs from melanoma patients with and without SBS7a mutation signature based on the use of PRKDC inhibitor or control (two-way ANOVA followed by Tukey’s multiple comparison test). The data are presented as mean SEM, * p < 0.05; ** p < 0.01; *** p < 0.001.

DOI